Category: Allies & Partnerships


Your Opportunity to Help Advance Melanoma Research

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 24 April 2018 In Allies & Partnerships

Beyond protecting yourself through sun-safety and skin-checks – one of the best ways you can observe Melanoma Awareness Month is by raising funds to support melanoma research!

Read More


Embrace Your Skin and Don't Be Anything that You Aren't

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 10 April 2018 In Allies & Partnerships, Melanoma Stories

This freckled red head was never meant to be tan, but it didn’t stop her from trying. Stefani Schuetz just wanted that ‘perfect glow’ that she hoped would help her fit in after moving to Florida. She was training for a triathalon – a race requiring swimming, cycling, and running – with her sister when everything changed. Her sister thought she saw a bug on the back of her leg – but this bug turned out to be much worse. Instead of a bug, Stefani found a suspect mole that she’d never noticed before. She knew she had to get it checked out, but money was tight for this single Mom; it took her four months to make it to the dermatologist for a biopsy.

Read More


Creating a New Generation of Melanoma Models

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 8 January 2018 In Allies & Partnerships, Science

We all can remember the eruption that happened when our 1st grade science teacher combined vinegar and baking soda together to represent a volcano. In some ways, this is just like experiments that take place every day in the search for better treatments, and ultimately a cure, for melanoma. In both instances, the researcher uses models to represent systems and phenomena that would otherwise be difficult or unethical to touch, see, or manipulate. Models are powerful things and we use them every day to make things easier to understand. In science, modeling is an essential component of our scientific process.

Read More


Introducing Clinical Trial Navigator: Start Searching Today

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 5 December 2017 In Allies & Partnerships, News, Science, Treatment

At MRA, we know that advancing science is our best bet in the fight against melanoma. More than 87,000 people in the US will be diagnosed with melanoma this year, and with these numbers on the rise, researchers are working harder than ever to find new and better treatment options. In fact, there are over 300 clinical trials happening in melanoma right now.

Read More


Connecting the Dots – Clinical Trials and Patient Engagement

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 15 November 2017 In Allies & Partnerships, Melanoma Stories, News

MRA is thrilled to announce the launch of the Melanoma > Exchange, a melanoma treatment and research focused discussion group and support community. Through the Melanoma > Exchange, anyone touched by Melanoma can find support, ask questions, and build community among people who share a similar experience.

Read More


MRA Raises Millions of Dollars for Groundbreaking Melanoma Research

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 5 November 2017 In Allies & Partnerships, Events

Normally, when people are at a Sotheby’s auction, they come to bid on beautiful and rare art. On Nov. 2nd, however, more than 240 people came together at Sotheby’s Headquarters in New York City to raise their paddle in the fight against melanoma. Together, participants raised over $20 million to further advance melanoma research.

Read More


Safe and Sound: Balancing Safety with Innovation in American Sunscreens

By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 10 October 2017 In Allies & Partnerships, Policy, Prevention

Currently, Americans have access to 16 sunscreen active ingredients approved by the Food and Drug Administration (FDA) to prevent skin cancer. The last time a new OTC (Over the Counter) sunscreen ingredient was added to the FDA sunscreen monograph was 1999. Meanwhile, Europeans have access to 29 sunscreen active ingredients. In the United States there are currently eight new sunscreen ingredients that are pending FDA review, which have been used in Europe – many for over ten years. These new, and potentially better, active ingredients could allow sunscreens to last longer and provide better full spectrum coverage that could help us reverse trends of increasing melanoma incidence in this country. Unlike in Europe where sunscreens are classified as cosmetics, in the United States the FDA is required to evaluate all active ingredients in sunscreens as OTC drugs. Meaning, that all U.S. sunscreen ingredients must be found generally recognized as safe and effective (GRASE) in the same manner as other OTC medications. The FDA says that this is critical to keeping us safe, but is it possible to balance innovation and safety?

Read More


L’Oréal Paris USA-MRA Team Scientists shed light on how melanoma spreads

By Kristen Mueller, PhD | 29 August 2017 In Allies & Partnerships, Science, Treatment

MRA is extremely proud of the 289 investigators we have funded over the last decade and the exciting advances they have made toward ending suffering and death due to melanoma. While we can never highlight all of them at one time, we’re excited in this blog to highlight the work of the L’Oreal Paris USA sponsored MRA Team award.

Read More


Melanoma Research Alliance and the American Cancer Society Forge Research Partnership to Maximize Immunotherapy Benefit to Patients

By Pamela Goldsmith, MRA Director of Communications | 10 July 2017 In Allies & Partnerships, Science

The Melanoma Research Alliance (MRA) and the American Cancer Society (ACS) are partnering to fund much-needed research aimed at decreasing rare, but serious, side effects associated with checkpoint inhibitors in hopes of increasing further cancer immunotherapy benefit to patients.

Read More


LFFM Fundraising Event Again Reaches a Record Setting Year

By Pamela Goldsmith, MRA Director of Communications | 6 June 2017 In Allies & Partnerships, Events

Nearly 1,000 professionals from the leveraged finance community gathered for the sixth annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party raising a record $1.8 million in funds for the Melanoma Research Alliance (MRA), the largest private funder of melanoma research.

Read More


Login

×